Advanced ODT Technologies for Drug Development in Japan and the US

CMIC Group, the first and largest CRO in Japan with extended services in drug development and GMP manufacturing in the US, Japan and Asia, held a webinar Advanced ODT Technologies for Drug Development in Japan and the US on April 11, 2019.Since its introduction in the 1980s, the market of orally disintegrating tablet (ODT) has grown annually and ODTs are now available in a variety of therapeutic areas, both over-the-counter (OTC) and by prescription. ODT market is projected to reach US$21B in 2023.In this webinar, CMIC and Aprecia experts talked about advanced ODT technologies and its advantages in drug development.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Addressing common challenges in lentiviral vector clarification using closed, automated counterflow centrifugation systems

The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is becoming of higher importance.
Watch Now

Single-cell multiomic analysis of T cell exhaustion in vitro

This webinar will demonstrate how the power of a single-cell multiomic approach can be harnessed to comprehensively characterize T cells, and precisely monitor changes in differentiation, activation, and exhaustion signatures during in vitro cell stimulation.
Watch Now

MicroRNAs as biomarkers and therapeutic targets in TNBC

Abcam

Triple-negative breast cancer accounts for a disproportionate share of the total breast cancer morbidity rate due to its aggressive behavior and lack of effective targets.Join Dr. Brian Adams of Harvard Medical School as he discusses how microRNAs can serve as superior therapeutic agents in the fight against triple negative breast cancer.
Watch Now

Optimize This! Enhancing the Quality and Consistency of Cannabis and Extraction

Technology Networks

Everyone makes the best extracts. But are they optimized? And what does “the best” mean; does it mean high yield, high quality, or both? And what is quality anyway? Quality begins in the cultivation process and continues throughout the handling of the product from seed to sale. At OutCo, we’ve studied our production pipeline and extraction methodologies to offer optimized products to our patients. Finding the ideal balance between yield and consumer rating, we were able to optimize extraction protocols for controlled mixtures of compounds. Our custom methods enable us to create products with designer cannabinoid and terpene ratios, customized to patients’ and doctors’ needs. All of this was achieved in an efficient manner through the use of design of experiment (DoE) techniques, and continuous improvement of all processes.
Watch Now

Spotlight

resources